Recently, we launched Real World Talk with COTA – a podcast that brings together thought leaders from across our industry to discuss real-world data (RWD) and its impact on drug development and cancer care.
As a company, we are always looking for new and innovative ways to amplify the understanding and application of RWD because we believe everyone touched by cancer deserves a clear path to the right care. The podcast brings together and highlights industry leaders who are working to accelerate the use of real-world data.
To kick off the series, FDA’s Dr. Amy Abernethy, spoke with COTA’s CEO, Michael Doyle around how RWD has helped address the ongoing pandemic. “Real-world data can help us understand the story of a disease. It can help us prioritize treatments that might work. It can help us understand and put those treatments into context.” – Dr. Amy Abernethy
Subscribe here and stay tuned as we launch our next installment of episodes that will focus on the use of RWD by oncology providers. Guests include the Mayo Clinic’s Rafael Fonseca, MD and The Center for Cancer and Blood Disorders CEO, Barry Russo. Additionally, if you’re interested in being a guest, or would like to suggest someone for an upcoming episode, reach out to us via our contact form. Thanks for listening!